per 100 person-years) and 35 OHS 2-5 (8.8 per 100 person-years), adjusted hazard ratio (HR) 0·59, 64 95% confidence interval (CI) 0·35 to 0·99], but rates were similar thereafter. The rate of the 65 secondary outcome was lower with conservative management during 12 years of follow-up [14 66 events (1.6 per 100 person-years) versus 38 events (3.3 per 100 person-years), adjusted HR 0·37, 67 95% CI 0·19 to 0·72]. 68
Conclusions and relevance -Among adults diagnosed with unruptured bAVM, the use of 69 conservative management compared with intervention was associated with better clinical 70 outcomes over 4 years. Longer follow-up is required to understand whether this association 71 persists. 72
INTRODUCTION 73
74 Unruptured brain arteriovenous malformations and their associated feeding/nidal arterial 75 aneurysms (collectively termed 'bAVM') have ~1% annual risk of intracranial hemorrhage, 1, 2 which 76 has a one year case fatality of 12%, 3 in studies lasting up to ten years. 4 Interventional treatment 77
('intervention') by neurosurgical excision, endovascular embolization, or stereotactic radiosurgery 78 can be used alone, or in combination, to attempt to obliterate bAVMs, dependent on their 79 vascular anatomy. 5 Because interventions may have complications 6 and the untreated clinical 80 course of unruptured bAVMs can be benign, [1] [2] [3] [4] some patients choose conservative management 81 (without intervention). Unruptured bAVM intervention has been compared with conservative 82 management in a concurrent control group in just one randomized trial (ARUBA 83
[ISRCTN44013133]) [7] [8] [9] and only a few observational studies, all of which have shown harm from 84 intervention in the short-term. 10, 11 Guidelines have endorsed both intervention and conservative 85 management for unruptured bAVMs. 12, 13 Therefore, we began a study in 1999 to assess the long-86 term outcome for adults affected by bAVM, with or without intervention, in everyday clinical 87 practice. 14 In this analysis, we included adults in SIVMS with a radiographically-or pathologically-confirmed 111 first-in-a-lifetime definite diagnosis of a bAVM in 1999-2003 or in 2006-2010 inclusive, which was 112 unruptured when diagnosed. The term 'bAVM' included associated nidal/feeding arterial 113
aneurysms, but not intracranial aneurysms remote from the bAVM its arterial supply. We 114 classified adults as receiving intervention if they underwent any of the following treatments for 115 their unruptured bAVM, either alone or in any combination, before the end of follow-up: 116 microsurgical excision, stereotactic radiosurgery, or endovascular (glue or coil) embolization. We 117 classified adults as undergoing 'conservative management' if they did not receive any of these 118
interventions. Decisions about intervention were left to patients and their physicians. 119 120 121
Diagnostic verification 123 124
Four experienced neuroradiologists verified certainty of bAVM diagnosis on diagnostic brain 125 imaging that had been performed in clinical practice (supported by the Systematic Image Review 126 System tool; http://www.neuroimage.co.uk/sirsinfo/). They determined surgical eloquence of 127 nidus location 16 and used catheter angiography to describe vascular anatomy 10 or MRI to measure 128 nidus size. 17,18 129 130
Baseline characteristics 131 132
We reviewed family (general) practitioner and hospital medical records to establish demographics, 133 medical histories, and the consequences of bAVM presentation on the Oxford Handicap Scale 134 (OHS), which is a derivative of the modified Rankin Scale, ranging from 0 (no symptoms) to 6 135 (death). 19 We reviewed these medical records, brain imaging and reports of pathological 136 examinations to classify the mode of bAVM presentation and clinical outcome events during 137 follow-up. When assessing clinical events at presentation and during follow-up, we also classified 138 whether they were definitely, possibly, or definitely not attributable to the bAVM or an 139 intervention complication. We classified events as possibly attributable to the bAVM when clinical 140 features were anatomically consistent with bAVM location, but another cause (e.g. ischaemic 141 stroke) was possible and neuroradiological investigation had identified neither bAVM hemorrhage 142 nor an alternative cause. We regarded presentations as 'incidental' if the adult had been 143 asymptomatic or if we could not definitely relate their symptoms to the underlying bAVM (e.g. 144 headache); we attributed presentations to epileptic seizure(s) if a seizure was neither 145 symptomatic of a concomitant intracranial hemorrhage nor more likely to be due to another 146 cause.
148

Follow-up 149 150
The inception point for conservative management was an adult's presentation, which was the date 151 of symptom onset or medical consultation (if asymptomatic) that led to an investigation 152 diagnosing the bAVM. The inception point for intervention was the date of the first intervention 153
for an unruptured bAVM that proceeded after presentation. Follow-up occurred prospectively on 154 an uninterrupted annual basis, using a postal questionnaire to every adult's family practitioner and 155 annual surveillance of family practitioner and hospital medical records, to identify outcome events 156 that had occurred over the preceding year. Consenting participants completed postal 157 questionnaires on each anniversary of bAVM diagnosis, to identify outcome events and assess 158 handicap on the OHS. Two investigators (CPW or RA-SS) independently assessed symptomatic 159 clinical outcome events, 10 using all the contemporaneous clinical, radiographic and pathological 160 records available. In attributing the mode and cause of death we reviewed death certificates, 161 autopsy reports if performed, and clinical records and brain imaging if death occurred in hospital. 162 Extent of bAVM obliteration was assessed from reports of angiographic brain imaging after 163 intervention. We gave precedence to obliteration confirmed by catheter angiography, otherwise 164 we relied on magnetic resonance angiography. For analyses of clinical covariates, age was a continuous variable, OHS at presentation was 171 dichotomized into 0-1 versus 2-5, and mode of presentation was dichotomized into seizure(s) versus other (although, if following presentation a clinical event occurred which led to 173 intervention, this subsequent event became the mode of presentation in the intervention group). 174
We dichotomized bAVM nidus location into deep (involving the basal ganglia, internal capsule, 175 thalamus, hypothalamus, limbic system, or corpus callosum) versus other. We dichotomized 176 venous drainage into exclusively deep versus other, and bAVM nidus maximum diameter into 177 <3cm versus ≥3cm. We separately derived the bAVM Spetzler-Martin grade, which predicts the 178 likelihood of morbidity from bAVM excision based on bAVM size, venous drainage pattern, and 179 eloquence of surrounding brain (grade 1 lowest risk to grade 5 highest risk). 16 differences between intervention and conservative management determined by the log-rank test 213 and hazard ratio (HR) from Cox regression, with intervention as the referent category. We pre-214 specified multivariable analyses to adjust HRs when proportional hazards assumptions were 215 satisfied. 23 Covariates were selected from the following list, in the following order which was 216 determined by the clinical relevance and likely completeness of the covariates, until the number of 217 outcomes per covariate would be below ten with the addition of another covariate 20 : clinical 218 influences on functional outcome ([1] age at inception, [2] mode of clinical presentation, 24 
and [3] 219
baseline OHS score [for the primary outcome only]) and vascular anatomy that influences either 220 the risk of bAVM hemorrhage ( [4] bAVM nidus location and [5] bAVM venous drainage pattern 1,2 ) 221 or the risk of intervention ([6] maximum bAVM nidus diameter 10, 16 ). Covariates were entered simultaneously into the regression model. In a supplementary analysis, we derived a model to 223 predict the occurrence of intervention (using age at presentation, receipt of a catheter angiogram, 224 and sex) and adjusted the multivariable models of the primary and secondary outcomes for these 225 propensity scores. subsequently underwent intervention). Adults receiving intervention were younger, more likely to 241 present with seizure(s), more likely to have a catheter angiogram and less likely to have a 242 maximum bAVM diameter >6cm (Table 1) . 19, range 0-97) following presentation (eFigure 1). Embolization was attempted but did not 260 proceed because of unsuitable vascular anatomy in four adults (subsequently embolization was 261 possible in one and three underwent stereotactic radiosurgery). Two-thirds received single-262 modality intervention and one-third received multi-modality intervention over median 12 months 263 (eFigure 2 and eTable 1). 83 adults had catheter angiography and 14 had magnetic resonance 264 angiography following their last intervention, demonstrating bAVM obliteration in 63% after 265 single-modality and 71% following multi-modality intervention (eTable 1). Adults undergoing 266 stereotactic radiosurgery had their most recent imaging study after mean 32±15 months following 267 their most recent intervention. 3). This was unrelated to bAVM or intervention (log-rank p=0·29) but attributable to deaths from 289 other causes (log-rank p<0·001); these differences disappeared after age-adjustment (eTable 2). adjusted HR 0·50, 95% CI 0·25-0·98), 25 including secondary outcomes that were possibly due to the 311 bAVM (18 vs. 39 events, 2.1 vs 3.3 per 100 person years, adjusted HR 0·43, 95% CI 0·23-0·78), or 312 reallocating the two adults who had intervention attempted but not given to the intervention 313 group (14 vs. 38 events, 1.6 vs 3.2 per 100 person years, adjusted HR 0·42, 95% CI 0·22-0·79). 314
315
We pre-specified a supplementary analysis of ARUBA's primary outcome (the composite event of 316 death from any cause or symptomatic stroke). However, the proportional hazards assumption was 317 violated (eFigure 5) precluding multivariable analysis, because of the excess of deaths of any cause 318 in the conservative management group in our study (Figure 1 and eFigure 3) . 319
A post hoc analysis restricted to adults who were OHS 0-1 at baseline did not change the 321 association between conservative management and the primary outcome (12 vs. 24 events, 5.5 vs 322 9.0 per 100 person years, adjusted HR 0·42, 95% CI 0·20-0·89 over four years) or secondary 323 outcome (7 vs. 20 events, 1.3 vs 2.5 per 100 person years, adjusted HR 0·35, 95% CI 0·14-0·87). 324
325
In post hoc analyses, we found differences between the two cohort epochs in some covariates. 326
Therefore, we added a cohort epoch term to our multivariable models, which had sufficient 327 outcomes to allow the addition of another covariate. The strength and statistical significance of 328 the associations in our multivariable analyses of the primary and secondary outcomes ( Table 2) In a prospective, population-based inception cohort study of adults with unruptured bAVM, we 340 found that conservative management was associated with a lower rate of progression to sustained 341 handicap or death of any cause over four years, and a lower risk of bAVM-related symptomatic 342 stroke or death over 12 years, having adjusted for baseline imbalances and performed several 343 sensitivity analyses. 344
One randomized controlled trial comparing conservative management with intervention for 346 unruptured bAVMs (ARUBA) was published recently. 8, 9 Non-randomized observational studies and 347 randomized trials sometimes concur, 26, 27 and in this case the similarities support the 348 generalizability of the results: treated participants were similar in age, sex, incidental mode of 349 presentation, lobar bAVM nidus location, superficial venous drainage pattern, and Spetzler-Martin 350 grades (Table 1) , and they received multi-modality intervention with the same frequency (eTable 351 1). 9 Furthermore, the association between conservative management and stroke or death related 352 to bAVM or its intervention over 12 years in this observational study (adjusted HR 0·37, 95% CI 353 0·19-0·72) was similar to the effect of conservative management on stroke or death of any cause 354 over six years in the ARUBA as-randomized analysis (HR 0·27, 95% CI 0·14-0·54). 9 The similarity of 355 the results of this observational study and ARUBA and the persistent difference between the 356 outcome of conservative management and intervention during 12-year follow-up in our study 357 support the superiority of conservative management to intervention for unruptured bAVMs, 358 which may deter these patients and physicians from intervention. 359
360
The strengths of this study include: thorough case ascertainment 15 ; a population-based sampling 361 frame to maximize external validity; a concurrent control group; sufficient time to allow the 362 effects of multi-modality intervention and stereotactic radiosurgery to be complete by the end of 363 follow-up; internal validity from using independent imaging review and outcome assessment with 364 reference to published criteria; minimisation of bias by using outcomes that were rated and 365 adjudicated independently of the doctors caring for these adults in clinical practice; and 94% 366 completeness of the entire duration of follow-up for all adults. The clinical outcome and 367 proportions of bAVM obliterated by intervention in Scotland appear generalizable, by being at 368 least as good as reports in systematic reviews 6 and the USA Nationwide Inpatient Sample database. 28 Furthermore, the rate of hemorrhage from unruptured bAVMs (18%, 95% CI 11-30 370 after 12 years; Figure 3 ) was consistent with reported rates. 1,2 371 372 This study also has several limitations. Our comparison of intervention and conservative 373 management was not randomized, so selection bias led to adults undergoing intervention being 374 younger, presenting more often with seizure(s), and having smaller AVM nidus diameters (Table  375 1). Confounding by indication may affect our results, but the bAVM intervention group appeared 376 to have favourable prognostic factors, and adjustment for propensity to intervention did not 377 change our findings. Both the robustness of our findings in sensitivity analyses, as well as 378 consistency between our findings and ARUBA 9 are reassuring. The primary outcome did not 379 include the baseline measurement of handicap (and therefore allowed recovery from initial 380 presentation) and crucially it allowed for recovery from the known early complications after 381 intervention by requiring handicap to be sustained for at least two successive years. The primary 382 outcome was difficult to interpret beyond four years, because of the high frequency of bAVM-383 unrelated deaths in the conservative management group, which was attributable to the imbalance 384 in age between the groups at baseline. Long-term follow-up in both this study as well as the 385 ARUBA trial is needed to establish whether the superiority of conservative management will 386 persist or change. Each bin includes values greater than or equal to the lower limit and less than the upper limit. eFIGURE 2 -Time between first and last intervention for an unruptured brain arteriovenous malformation or associated arterial aneurysm among the 103 adults in the intervention group. Each bin includes values greater than or equal to the lower limit and less than the upper limit. 
